Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPICILLIN\SULBACTAM vs ANAGRELIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPICILLIN\SULBACTAM vs ANAGRELIDE: Safety Overview

Metric AMPICILLIN\SULBACTAM ANAGRELIDE
Total FAERS Reports 1,655 1,336
Deaths Reported 308 131
Death Rate 18.6% 9.8%
Hospitalizations 791 580
Average Patient Age 55.5 yrs 69.6 yrs
% Female Patients 45.5% 58.5%
FDA Approval Date N/A Apr 18, 2005
Manufacturer N/A ANI Pharmaceuticals, Inc.
Route N/A ORAL
Marketing Status N/A Prescription